ATX-MS-1467 Induces Long-Term Tolerance to Myelin Basic Protein in (DR2 × Ob1)F1 Mice by Induction of IL-10-Secreting iTregs
ConclusionOur results suggest that ATX-MS-1467 can induce splenic iTregs and long-term tolerance to MBP with the potential to partially reverse the pathology of multiple sclerosis, particularly during the early stages of the disease.FundingEMD Serono, Inc., a business of Merck KGaA.
Source: Neurology and Therapy - Category: Neurology Source Type: research
More News: Autoimmune Disease | Brain | Disability | Encephalitis | Immunotherapy | Merck | MRI Scan | Multiple Sclerosis | Neurology | Pathology | Study